An experimental drug designed to lower lipoprotein(a) and prevent heart attacks failed to reduce cardiovascular events in a major study, researchers reported Saturday.
New research shows moderate aerobic exercise physically reshapes the nerves controlling the heart, revealing distinct structural changes in the left and right stellate ganglia.